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Abstract 
 
The conventional method for the axillary artery insertion of Impella 5.0 is a non-
tunneling route of the side-graft. We present an alternative technique in order to 
facilitate device insertion and to ensure protection from potential wound 
contamination. The technique consists of exiting the graft separately and away 
from the main incision with an intact skin and subcutaneous fat between the two 
sites. By proper isolation of the main wound, the risk of infection can thus be 
largely mitigated. Furthermore, this technique allows a better landing entry angle of 
graft insertion; the resulting smoother curve trajectory leads to facile device 
insertion, while the risk of kinking after resumption of flow is readily avoided. A 
further possible advantage would be a less likely to produce thrombosis at the 
anastomosis. Differences of this technique have already been reported for 
insertions of extracorporeal membrane oxygenation (ECMO), and for aortic 
dissections and aneurysms. Our experience in 8 cases suggests the applicability 
of our method to access the axillary artery for Impella 5.0 insertion. 
Keywords: arterial cannulation, axillary artery, mechanical circulatory support, 
axial flow left ventricular-aortic pump (Impella 5.0). 
Introduction 
 
Utilization of temporary (< 6 days)mechanical circulatory left ventricular (LV) assist 
devices has allowed circulatory support and recovery of the LV in the treatment of 
cardiogenic shock, or in the setting of acute left heart failure. In that regard, the 
use of Impella 5.0 ventricular support system (Abiomed Inc., Danvers, MA) is 
rapidly expanding; however, on occasion the LV recovery requires the device to be 
in place for longer-time period where wound infection may be a problem. 1, 2 
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Relevant technical steps 
After confirmation of a suitable candidate, anesthesia is induced, a 
transesophageal echo probe positioned, and a pulmonary central catheter is 
introduced into the pulmonary artery. We prefer to perform the implantation in the 
hybrid operating room. 
Prior to procedure, ultrasound imaging is a key investigation of the axillary artery 
that allows safe feasibility of a peripheral access, Figures 1A, B. This artery should 
have a minimum caliber of 6.20 mm which is needed for the Impella device’s 
implantation to proceed. The operative field should include both infraclavicular and 
groin regions exposed in case additional access is needed. 
A 
B 
Figure 1 A, B. The right axillary artery sizing is done using a handheld 
ultrasound (GE Healthcare LOGIQe, Milwaukee, WI), 5-12 MHZ frequency 
conversion probe. 
 
 
The VAD Journal: https://doi.org/10.13023/vad.2018.10 Page 3 of 9 
 
The VAD Journal: The journal of mechanical assisted circulation and heart failure 
The infraclavicular exposure of the axillary artery (AA) starts with locating the 
coracoid process which can be felt easily under the skin. The coracoid process 
marks the most lateral border of an approximately two inch skin incision inferior 
and parallel to the clavicle. After opening the deep clavipectoral fascia, the tendon 
of the pectoralis minor muscle is divided (partially or totally) near its insertion on 
the coracoid process.  
Blunt blades Adson Cerebellum (V Mueller, Franklin Lakes, NJ) Retractor are 
cranked up for retraction of pectoralis major muscle, and a Karmody Vascular 
Spring Retractor (V Mueller) is used for deeper axillary fat retraction. 
Except for the sub-adventitial AA isolation, no sharp dissection is used once the 
AA has been visualized to avoid any trauma to this delicate vessel and to the 
brachial cords. Instead, a Kittner dissector (peanut) is used to gently tease-off the 
local connective tissue surrounding the vessel. Most of the time, the AA is 
pulseless in such patients who may be managed with extracorporeal LV support. 
The nerves to the pectoralis major muscle are preserved to avoid subsequent 
atrophy of this muscle. The thoracoacromial arterial branch (TA) of the AA marks 
the medial border of the anastomosis. As is done in the femoral artery exposure, 
small vessel tributaries are not cauterized but rather are ligated in continuity with 
fine silk (4.0) ties or hemoclipped. These tributaries are often accompanied by 
lymphatic channels which will not coagulate with the electric current and thus 
might lead to the postoperative lymphatic leaks. At this point, the lateral and 
medial brachial plexus cords are particularly vulnerable, and care should be taken 
not to cut or injure them through excessive diathermy heat. The AA is freed 
subadventitially and 2 retraction tapes are used to facilitate its exposure. A double-
looped tape can be placed so as to straddle the TA branch3.  This not only controls 
the branch but also prevents slippage. The other tape is placed distally to 
accommodate a distance of at least 1.2 cm so that a 10 mm Hemashield Platinum 
woven double velour vascular graft (MAQUET Cardiovascular LLC Wayne, NJ) 
can be anastomosed in an end to side fashion.The access point is usually medial 
to the origin of the lateral thoracic artery. 
After administering intravenously 5 to 10,000 units of heparin, a small Cooley-
Derra clamp (V Mueller) tangential occlusion clamp or two straight or profunda 
vascular clamps are applied across the artery between the snares. Then the AA is 
incised longitudinally, and the end to side anastomosis is completed with 5.0 
proline suture. After completion of the anastomosis, meticulous hemostasis is 
imperative especially since these devices require postoperative heparinization.  
The graft is tunneled out of the infraclavicular pocket by subcutaneous passage 
and a small incision is carried out at the shoulder exit wound site about 2” away 
from the main incision, Figures 2 A, B, C. 
Keeping the side graft straight and aligned as it enters the shoulder area, 
depending on the AA anatomic depth dictates, should result in a trajectory without 
kink. The 23 Fr (6 cm long) peel-away introducer with hemostatic valve is inserted 
over the catheter shaft into the graft, and secured with the graft lock.  
 
The VAD Journal: https://doi.org/10.13023/vad.2018.10 Page 4 of 9 
 
The VAD Journal: The journal of mechanical assisted circulation and heart failure 
A
B 
C 
Figure 2 A, B, C. Intra-
operative photographs 
showing the right 
axillary artery 
cannulation after 
completion of an end-to-
side anastomosis 
through a 10-mm side 
graft. The exit wound is 
being prepared, with the 
surgeon standing on the 
right side of the patient.  
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The device catheter is then carefully advanced into the left ventricle. At this stage, 
the ACT is maintained around 200 seconds. The device is advanced into the left 
ventricle loaded on a 0.035 inch guidewire with the use of both transesophageal 
echocardiography and fluoroscopy guidance. When both a correct Impella catheter 
position across the aortic valve and a pulsatile placement signal are documented, 
the device is activated after removing the wire and the peel away introducer. 
Thereafter, the repositioning sheath is advanced to the arteriotomy site. 
The flow rate is ramped up to a maximum P-9 level. All the flows were satisfactory, 
and the patients became hemodynamically stable. The trimmed graft flush under 
the skin is then secured around the catheter using a heavy silk tie (#5). The 2 
incisions are closed in layers and the skin is stapled. Antibiotic wound irrigation is 
optional. 
Explantation technique 
Under general anesthesia the surgical areas included the entire chest, right deltoid 
region and the right groin. The surgical areas are draped separately as a 
preemptive way to avoid contamination at the time when the assistant surgeon 
pulls out the device from under the sheaths. Systemic antibiotic was administered. 
The old staples and anchoring skin sutures of the repositioning device were 
removed and the incision was reopened using only blunt dissection to avoid new 
tissue trauma. At this point the old Hemashield graft was exposed and vessel 
looped for potential bleeding control. The old surgical fragments were removed, 
and deep wound culture was taken. The area was copiously irrigated with 
Bacitracin solution. The main wound was draped separately from the outer area 
where the device has been anchored. 
Under trans-esophageal echocardiography and keeping the pump running at ramp 
2, the device was withdrawn so the tip of the sheath was just above the aortic 
valve. After this step, the pump was shot off and the device was withdrawn 
afterward the vessel loop was snugged around the graft for bleeding control. A 
vascular TA 30 stapler was used to sever the graft just 1 cm above the axillary 
anastomosis and it was hemostatic. Thrombotic morcels were retrieved from the 
stump of the graft to avoid potential distal arm embolization. A representative 
thrombus material was sent for pathology examination. The wound was again 
irrigated with Bacitracin solution and closed in layers. 
We have employed this technique for cardiogenic heart failure in 8 cases with 
good success. Two cases were due to viral myocarditis, and two cases due to 
postcardiotomy cardiogenic shock. The remaining cases were due to idiopathic 
cardiomyopathy. In those patients who survived, the graft was excised between 4 
and 30 days post LV assistance with a mean of 11 days. Despite perioperative 
heparinization, there have been no bleeding or hematoma formation, therefore no 
transfusions were required due to perioperative blood loss. Furthermore, there 
were no wound infections, kinking, cannulation issues, or device malposition. The 
mean age was 66 years (SD ± 14; range: 48-76, 2 females) with 2 deaths: 1 due to 
septicemia related to sacral ulcers, and 1 to pneumonia. The mean pump flow was 
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4.5 ± 0.4 L/min. The remaining characteristics and patient outcomes are outlined in 
the table 1. 
 
Table 1.  Patient characteristics and postoperative outcomes 
 
Case Age Sex Diagnosis Ana-
stomo-
tic blee-
ding 
Wound 
Infection 
Flouro 
time 
(min) 
Pump 
Flows 
L/min 
Days 
on 
Impella 
Follow up Death 
<30 
days 
1 76  M Cardiogenic 
shock, 
STEMI 
No No 13.9 4.9 2 Right heart failure, 
Died after Impella 
RP placed 
Y 
(2d) 
2  
Right 
axillary 
76 M Cardiogenic 
shock, 
STEMI 
No No 8.8 4.4 12 Removed, pump 
thrombosis 
N 
3 
Left 
axillary 
76 M Cardiogenic 
shock, 
STEMI 
No No 
Enterobacter 
bacteremia 
(pneumonia) 
6.8 4.5 12 Mitraclip placed 
for mitral 
regurgitation 
Y 
(23 d) 
4 48 F Viral 
myocarditis 
No No 7.5 3.6 15 D/C to quaternary 
care, D/C LTACH 
N 
 
5 74 M Cardiogenic 
shock s/p 
CABGx3 
No No 17 4.5  9 D/C Rehab N 
 
6 52 F Decompen-
sated 
systolic HF 
No No 7.9 5.0 4 Heart transplant N 
 
7 75  M Decompen-
sated 
systolic HF 
s/p CABGx4, 
MVR, TV 
repair 
No No 
Impella 
removed for 
bacteremia, 
source:sacral 
wound 
3.8 4.5 30 Alive at 30 days N 
 
8 48 M Cardiogenic 
shock, 
myocarditis  
No No 4.4 4.9 8 D/C home N 
 
 
CABG= coronary artery bypass , D/C = Discharged, HF= heart failure, LTACH= 
Long term acute care hospital, MVR= mitral valve replacement, STEMI= ST 
elevation myocardial infarction, TV=tricuspid valve 
Discussion 
The conventional placement of the axillary artery cannulation is a non-tunneling 
technique. It was originally described by Sabick et al with a side graft and was 
associated with low morbidity compared with cannulating the artery directly4,5. 
However, in that report the cannulation was only used temporarily during the 
operation as inflow for cardiopulmonary bypass. 
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The main advantages to the tunneling technique compared to conventional 
placement are the prevention of wound contamination, either in the immediate 
postoperative period, or in the case of requiring longer-term circulatory support. 
A report by Mastroianniet et al. indicates a wound infection rate of 7%, one case 
(Methicillin resistant Staphylococcus aureus) in 14 patients using the conventional 
technique.6 The incidence of bleeding from the arterial outflow graft as reported by 
others was 17.3 % (14 patients) using an arterial inflow by a side graft sewn to the 
axillary artery for extracorporeal membrane oxygenation support in a cohort of 308 
patients.7 
Furthermore, it is well known that patients in heart failure are prone to systemic 
infection due to their compromised immune defense system.8 Based on that 
notion, it is our belief that wound infection rates after mechanical circulatory 
support device implantation is underreported.  
The second advantage of this technique is a potential decrease in clot formation at 
the anastomotic site between the graft and the recipient axillary artery. This is 
based on a smoother landing site due to the tunneling, with less formation of eddy 
current. This assertion should be verified in further studies. 
The AA is chosen as the first choice implantation as opposed to other  peripheral 
access because it allows ambulation, and often times one or both groin vessels 
may have already been used either for extracorporeal membrane oxygenation, or 
for a temporary right or left ventricular support (Impella 2.5 or Impella CP) before 
upgrading to Impella 5.0 implantation. Finally, the axillary artery is rarely calcified 
or is involved in arteriosclerosis. 
The graft length must be carefully judged following passage under the shoulder 
subcutaneous tissue. Redundant graft, which leads to kinking, as well as 
overstretching which leads to tension on suture line, must both be avoided. 
Tunneling the graft into the operative field prior to performing the anastomosis may 
limit the hand movement of the operating surgeon. 
The mean axillary artery diameter in the adult human is 6.38 mm (median 6.2, SD: 
1.57 mm), and this size is sufficient for a 21 Fr microaxial pump motor to be 
introduced without difficulty in the majority of cases.10 An endovascular dilator 
(Cook Medical, Bloomington, Indiana), or a Garret dilator 5-6 mm tip flexible shaft 
(Piling surgical instruments, Morrisville, NC) may be used to predilate the vessel if 
necessary, Figure 3 A, B. If one AA is small, some patients have asymmetrically 
sized vessels; therefore, the other side can be checked. If still unable to insert then 
convert to venoarterial extracorporeal membrane oxygenation. 
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A 
B 
Figure 3 A, B. Photographs of Garret vascular dilator and the endovascular 
dilator. 
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